ISSN: 2530-0164

Indexed in:

Index Medicus/MEDLINE, Excerpta Medica/EMBASE, SCOPUS, Science Citation Index Expanded, Journal Citation Reports/Science Edition, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.8

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.474

View more metrics

Journal Information

Special content about coronavirus SARS-CoV-2 (COVID-19) in Endocrinología, Diabetes y Nutrición

A novel approach to finding the compositional differences and biomarkers in gut microbiota in type 2 diabetic patients via meta-analysis, data-mining, and multivariate analysis

Faezeh Ebrahimi, Hadi Maleki, Mansour Ebrahimi, Amir Hossein Beiki

10.1016/j.endinu.2025.501561

Available online 11 March 2025

Effect of glucagon-like peptide-1 receptor agonists on the risk of major adverse limb events in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials

Fernando Garagoli, Walter Masson, Leandro Barbagelata, Martín Lobo

10.1016/j.endinu.2025.501562

Available online 10 March 2025

Características clínicas y manejo de la diabetes tipo 2 en la atención primaria de España. Estudio SED2

Violeta Antonio-Arques, Berta Fernandez Camins, Bogdan Vlacho, Joan Barrot, Jorge Navarro Pérez, Edelmiro Menéndez Torre, Didac Mauricio, Josep Franch-Nadal

10.1016/j.endinu.2025.501543

Available online 13 February 2025

PPGAI index as a photoplethysmographic biomarker for type 2 diabetes mellitus

Alessandro Gentilin, Antonio Cevese

10.1016/j.endinu.2024.07.009

Endocrinol Diabetes Nutr. 2025;72:

¿Estamos infradiagnosticando el deterioro cognitivo en pacientes con diabetes mellitus tipo 2?

Antelm Pujol, Pilar Sanchis, María I. Tamayo, Lluís Masmiquel

10.1016/j.endinu.2024.07.001

Endocrinol Diabetes Nutr. 2024;71:454-5

Predictive value of circulating miR-409-3p for major adverse cardiovascular events in patients with type 2 diabetes mellitus and coronary heart disease

Liang Cao, Xiangrong Pan, Ying Li, Wei Jia, Jiayang Huang, Jian Liu

10.1016/j.endinu.2024.05.009

Endocrinol Diabetes Nutr. 2024;71:372-9

Association between the rs12654778 SNP of the β-2 adrenergic receptor and LDL cholesterol levels in the Chilean adult population

Carlos González-Contreras, Miquel Martorell, Natalia Ulloa, Carolina Ochoa-Rosales, Felipe Díaz-Toro, Fanny Petermann-Rocha, Carlos Celis-Morales, Marcelo Villagran, Lorena Mardones

10.1016/j.endinu.2024.06.005

Endocrinol Diabetes Nutr. 2024;71:397-404

Potential of insulin deprescription adding a GLP-1 receptor agonist as a therapeutic strategy to improve the metabolic profiles of patients with type 2 diabetes mellitus

Victor Perez de Arenaza Pozo, Jersy Cárdenas Salas, Clotilde Vázquez Martínez

10.1016/j.endinu.2024.05.013

Endocrinol Diabetes Nutr. 2024;71:405-7

Influencia de la presencia y tipo de enfermedad cardiovascular sobre el riesgo de mortalidad de los pacientes con diabetes tipo 2: estudio DIABET-IC

José Antonio Gimeno Orna, Ana Belén Mañas Martínez, Luis Rodríguez Padial, Manuel Anguita Sánchez, Vivencio Barrios, Javier Muñiz García, Antonio Pérez Pérez

10.1016/j.endinu.2024.03.008

Endocrinol Diabetes Nutr. 2024;71:278-89

Open Article